GlassScriptPhysician profile
Stacy M Brown
NPI 1497185284
$3,085.38
in general payments reported to CMS, 2019-2025
32 companies · $618 in 2025
The $618 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $483 · 2023: $916 · 2024: $958 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,243 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,242.76 |
| Education | $248.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $636.00 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $512.73 | 2022-2025 | Myrbetriq, Xtandi, Veozah |
| 180 Medical, INC. | $281.13 | 2021-2025 | |
| Pfizer INC. | $207.83 | 2022-2025 | |
| Coloplast Corp | $155.01 | 2023-2024 | Speedicath, Porges Coloplast |
| Convatec INC. | $123.37 | 2023-2025 | |
| Janssen Biotech, INC. | $113.56 | 2022-2023 | |
| Urovant Sciences INC | $107.95 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $101.53 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $98.18 | 2023-2024 | Pylarify |
| Immunitybio, INC. | $95.69 | 2024-2025 | |
| Abbvie INC. | $76.86 | 2022-2025 | |
| Urogen Pharma, INC. | $57.87 | 2025 | |
| Emd Serono, INC. | $54.55 | 2023 | Bavencio |
| Tolmar, INC. | $49.43 | 2023-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $46.82 | 2023-2025 | Urolift, Barrigel |
| Myriad Genetic Laboratories, INC. | $39.83 | 2023 | Prolaris |
| Merck Sharp & Dohme LLC | $38.49 | 2022-2024 | Keytruda, Welireg, Lynparza |
| Procept Biorobotics Corporation | $35.29 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Telix Pharmaceuticals | $31.75 | 2025 | Illuccix |
| Axonics, INC. | $29.46 | 2022 | |
| Myovant Sciences INC. | $28.15 | 2022 | |
| Glaxosmithkline, LLC. | $27.72 | 2021-2022 | |
| Smith+Nephew, INC. | $17.92 | 2023 | Stravix Pl |
| Laborie Medical Technologies Corp. | $17.19 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $16.37 | 2024 | |
| Baxter Healthcare | $16.19 | 2022 | |
| Photocure INC | $15.65 | 2024 | Cysview |
| Boston Scientific Corporation | $14.61 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.71 | 2022 | |
| Amgen INC. | $12.96 | 2023 | Prolia |
| Novo Nordisk INC | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.